The Thalassemia center of Antalya state hospital: 15 years of experience (1994 to 2008)

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 1, 2013, Pages 24-27

  Canatan, Duran ^a  

^a Akdeniz Kan Hastaliklari Vakfi   (Turkey)

Author keywords

complication; endocrine; thalassemia; transfusion

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; CYTOMEGALOVIRUS ANTIBODY; HEPATITIS A ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; CARDIOMYOPATHY; CHILD; DIABETES MELLITUS; FEMALE; GROWTH RETARDATION; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OSTEOPOROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SICKLE CELL BETA THALASSEMIA; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; TORQUE TENO VIRUS INFECTION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; FEMALE; HIV; HIV INFECTIONS; HOSPITALS, STATE; HUMANS; HYPOTHYROIDISM; MALE; PROGNOSIS; THALASSEMIA; TIME FACTORS; TURKEY; YOUNG ADULT;

EID: 84871750840     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182755f1e     Document Type: Review

References (21)

1. Aksoy M, Lekin EW, Maurant AE, et al. Blood groups, hemoglobins and thalassemia in Southern Turkey and Eti Turks. Br Med J. 1958;2:937-939.
2. Cavdar AO, Arcasoy A. The incidence of beta-thalassemia and abnormal hemoglobins in Turkey. Acta Hematol. 1971;45: 313-318.
3. Canatan D, Kose MR, Ustundag; M, et al. Hemoglobinopathy control program in Turkey. Community Genet. 2006;9:124-126.
4. Canatan D. Status of thalassemia and hemoglobinopathies in the World and Turkey. J Hematol Oncol. 2010;3(1 (Special Topics)):1-4.
5. Canatan D, Ozsancak A. A new donor system for patients with thalassemia: Blood mother and blood father. Asian J Transfus Sci. 2010;4:109-111.
6. Modell B, Darlison M. Global epidemiyology of hemoglobin disorders and derived service indicators. Bulltein of the World Health Organization. doi: 10247/BLT06. 036673.04/03/2008.
7. Canatan D, Oguz N, Guvendik I, et al. The incidence of alphathalassemia in Antalya.Turkey. Turk J Haematol. 2002;19: 433-434.
8. Canatan D, Karadogn C, Oguz N, et al. The frequency ofconsanguineous marriages in patients with hereditary blood disorders in South of Turkey. Community Genet. 2003;6:58.
9. Rund D, Rachmilewitz E. b-thalassemia. N Eng J Med. 2005;353:1135-1146.
10. Aslan I, Canatan D, Balta N, et al. Bone mineral density in thalassemia major patients from Antalya, Turkey. Int J Endocrinol. 2012;2012:573298, Epub June 20, 2012.
11. Nquven DD, Devita DA, Hirschler NV, et al. Blood donor satisfaction and intention of future donations. Transfusion. 2008;48:742-748.
12. Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37-43.
13. Coles SM, Klein HG, Holland PV. Alloimmunization in two multi-transfused patient population. Transfusion. 1987;21: 462-466.
14. Sirchia G, Zanella A, Parravicini A, et al. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion. 1985;25:110-112.
15. Canatan D, Karadogn C, Oguz N, et al. Red cell antibodies in patient with beta-thalassemia major. Blood Banking Transfus Med. 2003;1:121-123.
16. Sonmezoglu M, Aydinok Y, Canatan D, et al. Transfusion transmitted viral infections in transfusion dependent patients with thalassemia in Turkey: a multi-center study. Blood. 2004;104:3782.
17. Ozyurek E, Ergunay K, Kuskonmaz B, et al. Transfusiontransmitted virus prevalence in Turkish patients with thalassemia. Pediatr Hematol Oncol. 2006;23:347-353.
18. Canatan D, Temimhan N, Dinçer N, et al. Continous desferrioxamine infusions by an infusor in thalassemia major. Acta Pediatr. 1999;88:550-552.
19. Cappellini MD, Bejaoui M, Agaoglu L, et al. Iron chelation with deferasirox in adultsand pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood. 2011;118:884-93.
20. Ratip S, Modell B. Psychological and sociological aspects of the thalassaemias. Semin Haematol. 1996;33:53-65.
21. Canatan D, Ratip S, Kaptan S, et al. Psychosocial burden of beta-thalassaemia major in Antalya, southern Turkey. Soc Sci Med. 2003;56:815-819.